{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:52:20Z","timestamp":1792479140069,"version":"4.5.0"},"reference-count":21,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hidradenocarcinomas are rare, aggressive skin adnexal tumors of sweat gland origin that demonstrate a high potential for local recurrence, metastasis, and poor outcome. These neoplasms can derive from preexisting clear cell hidradenomas but more commonly appear de novo, with the molecular events responsible for the pathogenesis currently unknown. Historically, diagnosis has been difficult because of the few cases, inconsistent nomenclature, variable morphology of cells that compose the neoplasm, and confusion with other visceral metastatic tumors. Presentation is generally benign with an indolent clinical course that typically includes local and multiple recurrences. Despite wide-excision surgery, disease at regional lymph nodes and metastatic sites is common and linked to decreased survival. Currently, molecular markers of pathogenesis as well as effective forms of adjuvant chemotherapy are lacking. Future studies are required to identify the histopathologic and immunohistochemical features, which may facilitate diagnosis and foster development of molecularly targeted forms of adjuvant therapy.<\/jats:p>","DOI":"10.5858\/134.5.781","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T12:25:54Z","timestamp":1613132754000},"page":"781-785","source":"Crossref","is-referenced-by-count":61,"title":["Hidradenocarcinomas: A Brief Review and Future Directions"],"prefix":"10.5858","volume":"134","author":[{"given":"Steven","family":"Gauerke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"2021021103405968700_i1543-2165-134-5-781-b01","first-page":"591","article-title":"Tumors of sweat glands.","volume":"19","author":"Gates","year":"1943","journal-title":"Am. J. Pathol"},{"issue":"3","key":"2021021103405968700_i1543-2165-134-5-781-b02","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/1097-0142(195105)4:3<521::AID-CNCR2820040306>3.0.CO;2-E","article-title":"Carcinomas of sweat glands.","volume":"4","author":"Stout","year":"1951","journal-title":"Cancer"},{"key":"2021021103405968700_i1543-2165-134-5-781-b03","first-page":"123","article-title":"Pathology of sweat gland carcinomas.","volume":"3","author":"Berg","year":"1968","journal-title":"Pathol Annu"},{"issue":"pt 1","key":"2021021103405968700_i1543-2165-134-5-781-b04","first-page":"83","article-title":"Carcinoma of sweat glands.","volume":"22","author":"Cooper","year":"1987","journal-title":"Pathol Annu"},{"key":"2021021103405968700_i1543-2165-134-5-781-b05","volume-title":"Histopathology of the skin. 9th ed","author":"Elder","year":"2005"},{"issue":"9","key":"2021021103405968700_i1543-2165-134-5-781-b06","first-page":"1265","article-title":"Nodular hidradenocarcinoma on the scalp of a young woman: case report and review of literature.","volume":"30","author":"Ohta","year":"2004","journal-title":"Dermatol Surg"},{"issue":"4","key":"2021021103405968700_i1543-2165-134-5-781-b07","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5858\/2001-125-0498-COSG","article-title":"Carcinoma of sweat glands.","volume":"125","author":"Urso","year":"2001","journal-title":"Arch Pathol. Lab Med"},{"issue":"1","key":"2021021103405968700_i1543-2165-134-5-781-b08","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1034\/j.1600-0560.2000.027001030.x","article-title":"Genetic changes in sweat gland carcinomas.","volume":"27","author":"Takata","year":"2000","journal-title":"J Cutan Pathol"},{"key":"2021021103405968700_i1543-2165-134-5-781-b09","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1600-0560.2006.00536.x","article-title":"Hidradenocarcinomas: a histological and immunochemical study.","volume":"33","author":"Ko","year":"2006","journal-title":"J Cutan Pathol"},{"key":"2021021103405968700_i1543-2165-134-5-781-b10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0560.2006.00570.x","article-title":"Metastatic hidradenocarcinoma with demonstration of Her-2\/neu gene amplification by fluorescence in situ hybridization: potential treatment implications.","volume":"34","author":"Nash","year":"2007","journal-title":"J Cutan Path"},{"issue":"13","key":"2021021103405968700_i1543-2165-134-5-781-b11","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1158\/1078-0432.CCR-05-2376","article-title":"MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.","volume":"12","author":"Okabe","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2021021103405968700_i1543-2165-134-5-781-b12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-4608(95)00266-9","article-title":"A mucoepidermoid carcinoma of minor salivary gland with t(11;19)(q21;p13.1) as the only karyotypic abnormality.","volume":"87","author":"El-Naggar","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"2021021103405968700_i1543-2165-134-5-781-b13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng1083","article-title":"t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.","volume":"33","author":"Tonon","year":"2003","journal-title":"Nat Genet"},{"issue":"13","key":"2021021103405968700_i1543-2165-134-5-781-b14","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1158\/1078-0432.CCR-06-0791","article-title":"Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer.","volume":"12","author":"Kaye","year":"2006","journal-title":"Clin Cancer Res"},{"key":"2021021103405968700_i1543-2165-134-5-781-b15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.1978.01640140016004","article-title":"Apocrine gland adenoma and adenocarcinoma of the axilla.","volume":"114","author":"Warkel","year":"1978","journal-title":"Arch Dermatol"},{"issue":"2","key":"2021021103405968700_i1543-2165-134-5-781-b16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000421-199904000-00005","article-title":"Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment.","volume":"22","author":"Chamberlain","year":"1999","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"2021021103405968700_i1543-2165-134-5-781-b17","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.11327","article-title":"Sentinel lymph node analysis in patients with sweat gland carcinoma.","volume":"97","author":"Delgado","year":"2003","journal-title":"Cancer"},{"key":"2021021103405968700_i1543-2165-134-5-781-b18","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.142.10.1366","article-title":"Metastatic Hidradenocarcinomas: efficacy of capecitabine.","volume":"142","author":"Jouary","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"2021021103405968700_i1543-2165-134-5-781-b19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00006534-198708000-00027","article-title":"Malignant clear-cell hidradenoma.","volume":"80","author":"Lopez-Burbano","year":"1987","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"2021021103405968700_i1543-2165-134-5-781-b20","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/1097-0142(19840301)53:5<1222::AID-CNCR2820530533>3.0.CO;2-A","article-title":"Sweat gland carcinomas in children.","volume":"53","author":"Chow","year":"1984","journal-title":"Cancer"},{"key":"2021021103405968700_i1543-2165-134-5-781-b21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1097-0142(19890715)64:2<366::AID-CNCR2820640204>3.0.CO;2-R","article-title":"Response of eccrine adenocarcinomas to tamoxifen.","volume":"64","author":"Sridhar","year":"1989","journal-title":"Cancer"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/134\/5\/781\/2769682\/1543-2165-134_5_781.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/134\/5\/781\/2769682\/1543-2165-134_5_781.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:33:37Z","timestamp":1764790417000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/134\/5\/article-p781.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5,1]]},"published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.5858\/134.5.781","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}